Tolvaptan, an oral vasopressin antagonist, in the treatment of hyponatremia in cirrhosis. [electronic resource]
Producer: 20120612Description: 571-8 p. digitalISSN:- 1600-0641
- Administration, Oral
- Antidiuretic Hormone Receptor Antagonists
- Ascites -- complications
- Benzazepines -- administration & dosage
- Chronic Disease
- Female
- Health Surveys
- Humans
- Hyponatremia -- blood
- Liver Cirrhosis -- complications
- Male
- Middle Aged
- Prospective Studies
- Recurrence
- Sodium -- blood
- Tolvaptan
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.